Lesutype 50 Tablet contains Levosulpiride 50mg, a trusted gastroprokinetic agent indicated for the management of functional dyspepsia, gastroesophageal reflux disease (GERD), and delayed gastric emptying. It helps in improving gastric motility, relieving bloating, nausea, and post-meal fullness.
Levosulpiride works by selectively blocking dopamine D2 receptors in the gastrointestinal tract, enhancing acetylcholine release and promoting coordinated gastric and intestinal movement. This action supports faster gastric emptying and improved digestive comfort in patients with chronic gastrointestinal symptoms.
For distributors and healthcare suppliers, Lesutype 50 Tablet is a high-rotation gastrointestinal therapy product, commonly prescribed by gastroenterologists, physicians, and internal medicine specialists. The increasing prevalence of lifestyle-related digestive disorders ensures consistent market demand.
Adding Lesutype 50 Tablet to your gastrointestinal and digestive care segment offers strong opportunities in pharmacies, hospitals, gastro clinics, export markets, and third-party manufacturing. Its proven efficacy, excellent patient compliance, and wide prescriber acceptance make it a valuable product for pharmaceutical distribution.